European watchdog partially approves new Alzheimer's drug
DOMINICK REUTER/AFP/AFP Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light. "After re-examining its initial ...
ScienceAlert on MSN2d
Brain Autopsies Reveal a Potential New Culprit Behind Alzheimer'sUniversity of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...
A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...
1dOpinion
November is Alzheimer’s Awareness Month and New York has the second highest rate of Alzheimer’s disease in the U.S. NYC’s ...
Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...
Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved in the development and progression of Alzheimer’s disease.
Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...
14, joined together for a common cause: raising money to fund Alzheimer’s Association’s classes and resources for local ...
Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...
WJTV Jackson on MSN1d
Alzheimer’s Awareness Month in MississippiNovember is Alzheimer’s Awareness Month. According to the Alzheimer’s Association Mississippi Chapter, nearly 7 million ...
The $74.5 million grant will fund a study focused on an inherited genetic mutation that has been linked to Alzheimer's.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback